Fennec Pharmaceuticals CFO Robert Andrade sells 75,000 common shares for $883,500

PUBT · 2d ago
Fennec Pharmaceuticals CFO Robert Andrade sells 75,000 common shares for $883,500
  • Fennec Pharmaceuticals CFO Robert Andrade sold 75,000 common shares on Aug. 27 at USD 11.78.
  • He exercised stock options on Aug. 28 to acquire 21,928 common shares at USD 5.1.
  • Directly held common shares totaled 239,603 following the transactions.
  • Directly held stock options totaled 779,330 following the option exercise.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fennec Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001468308-26-000028), on August 28, 2026, and is solely responsible for the information contained therein.